• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

MJH Associates, Inc. Acquires Assets from UBM Life Sciences Group Becoming the Largest Privately Held Medical Media Company in the United States

Share:

February 4, 2019

MJH Associates‚ Inc., a leading independent full-service health care education, market research and multichannel medical communications company, has acquired media assets from the UBM Life Sciences Group (part of Informa PLC). The acquisition comes with seven offices — six in the U.S. and one in the United Kingdom — and over 220 associates.

The acquisition of UBM Life Sciences assets includes iconic multimedia platforms in the health care, animal care, pharma sciences and dental fields, as well as three pre-eminent veterinarian conferences. The integration of these brands will complement the existing MJH portfolio and, together, significantly extend access and engagement with meaningful health content. These new assets will form a new business unit within MJH called MultiMedia Healthcare, LLC. This combined entity makes MJH the largest privately held medical media company in the U.S.

“The strategic purchase of UBM Life Sciences’ media assets leaves no question that MJH is dedicated to remaining at the forefront of delivering trusted health care information now and into the future. It furthers our overall commitment to providing diverse stakeholders — from providers to patients to caregivers — access to trusted and timely resources to help inform care and optimize outcomes,” said Michael J. Hennessy, Jr., president of MJH Associates‚ Inc.

Tom Ehardt, executive vice president and managing director of the UBM Life Sciences Group added: “We are pleased to find a partner that is invested in engaging our valued audiences in new and exciting ways. MJH is an ideal fit for us as they understand how to deliver high-quality content in multimedia platforms and live events.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Ehardt will continue in his current role and serve as president of MultiMedia Healthcare, LLC, reporting to George Glatcz, COO of MJH.

The Life Sciences Group features 3 vertical markets. Some of the leading brands MJH has acquired are as follows:

  • Health care— Medical Economics, Patient Care, Practical Cardiology, Dermatology Times, Drug Topics, Ophthalmology Times, Psychiatric Times, Urology Times, Contemporary OB/GYN, Oncology, Dental Products Report and Managed Healthcare Executive.
  • Pharma — Pharmaceutical Technology, LC/GC, Pharmaceutical Executive, Spectroscopy, BioPharm International and Nutritional Outlook.
  • Animal Health — DVM360, Vetted and Firstline. Additionally, the animal health group produces the Fetch series of three live regional conferences.

MJH was advised by Oaklins DeSilva & Phillips.

Date: February 4, 2019

Source: The Business Journals

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Leveraging technology and digital tools to (finally) increase diversity in clinical trialsLeveraging technology and digital tools to (finally) increase diversity in clinical trials
  • Omega 3 Products Market 2019 Global Industry Growth, Size, Demand, Trends, Insights and Forecast 2025Omega 3 Products Market 2019 Global Industry Growth, Size, Demand, Trends, Insights and Forecast 2025
  • BIO: is COVID-19 Changing how Biopharmas Think of M&A? Not Really, say J&J and Takeda ExecsBIO: is COVID-19 Changing how Biopharmas Think of M&A? Not Really, say J&J and Takeda Execs
  • Italfarmaco Acquires 100% of Lacer, A Spanish Pharmaceutical Company That is a Leader in Health Care and Personal HygieneItalfarmaco Acquires 100% of Lacer, A Spanish Pharmaceutical Company That is a Leader in Health Care and Personal Hygiene
  • Pharma Clinical Trial Digitization Market 2020 Competitive Status and Industry ForecastPharma Clinical Trial Digitization Market 2020 Competitive Status and Industry Forecast
  • Entheon Biomedical Corp. Announces Acquisition of HaluGen Life Sciences Inc.Entheon Biomedical Corp. Announces Acquisition of HaluGen Life Sciences Inc.
  • State AGs urge Apple to Better Protect Reproductive Health DataState AGs urge Apple to Better Protect Reproductive Health Data
  • Livongo for Diabetes Solution Now Available to New Jersey State and School Health Plan MembersLivongo for Diabetes Solution Now Available to New Jersey State and School Health Plan Members

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications